Contact this trialFirst, we need to learn more about you.
Virus Therapy
VG2025 + Nivolumab for Advanced Cancer
Recruiting1 awardPhase 1
Gilbert, Arizona
This trial is testing a new treatment called VG2025, alone or combined with Nivolumab, in patients with advanced malignant solid tumors. VG2025 is injected directly into tumors to kill cancer cells, while Nivolumab helps the immune system fight cancer. The goal is to find effective treatments for patients who have not responded to standard therapies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service